The People's Chamber
ISSUE 80
← Transparency Hub

Dataset

Ministers' Meetings

13,967 records in this dataset. Showing rows 6701 to 6800 (page 68 of 140).

  • Simon Lightwood · DfT ministerial external

    2 Apr 2025

    Met Wrightbus

    Met with Jean-Marc Gales, the CEO of Wrightbus, at Wrightbus' manufacturing site in Belfast whilst on a visit as part of ongoing regular correspondence.

  • Gillian Merron · DHSC:

    2 Apr 2025

    Met Bayer

    To discuss women's and reproductive health

  • Daniel Zeichner · Defra's

    2 Apr 2025

    Met Rural Coalition, Countryside Land and Business Association, Action With Communities In Rural England, National Association of Local Councils, Rural Services Network, Council for the Preservation of Rural England, National Farmers' Union, National Innovation Centre for Rural Enterprise, Nuffield Foundation, Federation of Small Businesses, Plunkett

    Rural Taskforce meeting

  • Justin Madders · DBT’s

    2 Apr 2025

    Met Craft Bakers Association, Association of Convenience Stores, Sainsbury’s, Kingfisher, Retail Sector Council, British Retail Consortium, British Retail Consortium, British Retail Consortium, Unilever, Morrisons, Asda, Silkfred, Asos, Federation of Independent Retailers, Primark, The Very Group, The Toy Retailer Association, B&M Retail, Boots, Boots, Coop, John Lewis and Partners, H&M, Holland & Barrett, Pets at Home

    To discuss employment within retail sectors

  • Bridget Phillipson · DfE:

    2 Apr 2025

    Met Tony Gallagher, Editor; Steven Swinford, Political Editor, The Times

    To discuss priorities in education

  • Douglas Alexander · DBT’s

    2 Apr 2025

    Met SWA (Southwest Airlines)

    To discuss the US Update

  • Sarah Jones · DBT’s

    2 Apr 2025

    Met Automotive Sector Roundtable - SMMT, JLR, BMW MINI, Rolls Royce, Bently, Lotus, Aston Martin, McLaren, Toyota

    To discuss the impact of tarriffs on the automotive sector

  • Daniel Zeichner · Defra's

    2 Apr 2025

    Met Salmon Scotland

    Trade discussions

  • Catherine McKinnell · DfE:

    2 Apr 2025

    Met National Association of Head Teachers

    Bilateral meeting as part of ongoing engagement with key sector partners

  • Justin Madders · DBT’s

    2 Apr 2025

    Met Mark Francois MP and constituent

    To discuss career breaks for parents of seriously ill children

  • Jacqui Smith · DfE:

    2 Apr 2025

    Met UNISON

    To discuss further education and skills issues, in particular to discuss challenges faced by further education support staff

  • Mary Creagh · Defra's

    2 Apr 2025

    Met Bellway Homes, Gowling WLG, Ecogain, Eden Project, Environment Bank, Foresight Group LLP, Gresham House Asset Management Limited, Heineken, JRB Consulting LTD, KPMG International, Land Securities Group PLC, Legal and General Group, Octopus Investment Limited, Oxygen Conservation LTD, RSK Biocensus LTD, The Lifescape Project Limited, The Palladium Group, Wild Capital, Zurich UK

    A dinner event discussing private sector investment into nature

  • Jim McMahon · MHCLG:

    2 Apr 2025

    Met Tees Valley Combined Authority

    To discuss the Best Value Notice to Tees Valley Combined Authority

  • Peter Hendy · DfT ministerial external

    2 Apr 2025

    Met Sadiq Khan

    Meeting to discuss rail devolution and metroisation, the delivery of the Euston station campus and broader regeneration opportunities in the Euston area.

  • Gareth Thomas · DBT’s

    2 Apr 2025

    Met Craft Bakers Association, Association of Convenience Stores, Sainsbury’s, Kingfisher, Retail Sector Council, British Retail Consortium, British Retail Consortium, British Retail Consortium, Unilever, Morrisons, Asda, Silkfred, Asos, Federation of Independent Retailers, Primark, The Very Group, The Toy Retailer Association, B&M Retail, Boots, Boots, Coop, John Lewis and Partners, H&M, Holland & Barrett, Pets at Home

    To discuss employment within retail sectors

  • Janet Daby · DfE:

    2 Apr 2025

    Met Association of Directors of Children's Services

    Quarterly meeting with the President of Association of Directors of Children's Services

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met Sanofi, GSK, Astra Zeneca, Moderna, Roche, Almirall, Servier, Eisai, Menarani, Medical Research Council , Laboratory of Molecular Biology, Bristol Myers Squibb (BMS),Amgen, Chiesi, University of Manchester, Bayer AG, Merck, Eli Lilly, Takeda, University of Oxford, Teva, Mitsubishi Tanabe, Novartis, Union Chimique Belge (UCB), Incyte, Chugai, Gilead, Wellcome Trust, Biogen, Ipsen, Lundbeck , Francis Crick Institute, Boehringer, Merck, The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Pharmaceutical Research and Manufacturers of America (PhRMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Association of British Pharmaceutical Industry (ABPI)

    To discuss life sciences

  • Sarah Jones · DBT’s

    2 Apr 2025

    Met Aluminium roundtable: Bridgnorth Aluminium Ltd, Alvance British Aluminium, Hydro UK Aluminium, Novelis UK,Arconic Manufacturing (GB) Ltd, BACALL, Make UK,ALFED, Community Union

    To discuss the impact of tarriffs on the aluminium sector

  • Gareth Thomas · DBT’s

    2 Apr 2025

    Met COBA, Film London & BFC, Google, Together TV, North East Screen, BBC Film, Sky, TikTok, Channel 4, British Screen Forum, Protagonist Pictures, Nyman Libson Paul, Walt Disney Company, Amazon, Ukie, BFI, Erebus Pictures, Illuminated Films, Screen Scotland, BAFTA, British Screen Forum, Avalon Television, Olsberg, UK Cinema Association, British Screen Forum, Olsberg SPI, Warner Bros, Independent, BBFC, Artem Special Effects, Independent, Blazing Griffin, Wiggin, British Screen Forum, Sixteen Films, Space Studios, Sara Putt Associates/BAFTA, ODEON Cinemas Group Film Booking, Zanna Creative, Premier League, Independent, British Screen Forum, Everyone TV.

    To discuss exports, regional development and high streets

  • Ed Miliband · DESNZ

    2 Apr 2025

    Met Fortescue

    To discuss Fortescue's proposal of the Initiative Energie Maro-eurpe de Fortescue

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met Lundbeck, Chiesi, Ipsen, Eisai, Gilead, Sciences, Sanofi, Astra Zeneca, GlaxoSmithKline (GSK), Eli Lily, UCB, Servier Group, Almirall, Incyte, Moderna, Amgen, Takeda Pharmaceuticals, Menarini Group, Teva Pharmaceuticals, Bayer AG, Merck & Co, Roche Group, Mitsubishi Tanabe Pharmaceutical, Corporation, Novartis, Bristol Myers Squibb (BMS), Biogen, Chugai Pharmaceuticals

    To discuss life sciences

  • Gareth Thomas · DBT’s

    2 Apr 2025

    Met Clifford Chance, CIPR, ICAEW, Russell Reynolds Associates, CMI, KPMG, The City of London, Law Delivery Panel, Deloitte, Law Society of Scotland, McKinsey, Freshfields, Norton Rose Fulbright, ACCA, Bar Council, EY, Law Society, ICAEW, Herbert Smith Freehills, RICS, PageGroup, Make Architects, Deloitte, Knight Frank, PwC, Serco, Z/Yen, TCUK, REC, Arup, BSA, QPC, Mazars, Capgemini, Hymans Robertson, WPP, Accenture, Advertising Association, MCA, JLL, RIBA

    To update the PBSC on development of the PBS sector plan within the Industrial Strategy

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met Lundbeck, Mitsubishi Tanabe Pharmaceutical Corporation, Novartis, Astra Zeneca, GlaxoSmithKline (GSK), Sanofi, Bayer AG, Eli Lily, Gilead, Eisai , Merck & Co, Incyte, Amgen, Teva, Almirall, Servier, UCB, Roche Group, Menarini Group, Bristol Myers Squibb (BMS), Chiesi, Ipsen, Biogen, Takeda Pharmaceuticals, Moderna, The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Pharmaceutical Research and Manufacturers of America (PhRMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Association of British Pharmaceutical Industry (ABPI)

    To discuss life sciences

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met Eisai

    To discuss life sciences

  • Poppy Gustafsson · DBT’s

    2 Apr 2025

    Met Biopharmaceutical CEO Roundtable (Attendees: AstraZeneca, Chiesi, Moderna, Bristol-Myers Squibb, Pfizer, Amgen, Menarini, MSD, Johnson & Johnson, TEVA, Almirall, Merck, Incyte, Sanofi, Servier, IPSEN, Eisai, Novartis, Gilead, Bayer, Chugai, Eli Lilly, Roche, UCB, Mitsubishi, Lundbeck, Biogen, Boehringer Ingelheim, Takeda, GSK, ABPI, JPMA, EFPIA, INTERPAT, IFPMA, PhRMA)

    To discuss the UK life sciences commerical environment and investment in this sector

  • Poppy Gustafsson · DBT’s

    2 Apr 2025

    Met UCB Pharmaceuticals

    To discuss investment and the commericial environment for UK life sciences prior to the BCR

  • Poppy Gustafsson · DBT’s

    2 Apr 2025

    Met Bristol Myers Squibb

    To discuss investment and the commericial environment for UK life sciences prior to the BCR

  • Poppy Gustafsson · DBT’s

    2 Apr 2025

    Met Oversea-Chinese Banking Corporation

    To discuss OCBC's investment into the UK, HMG's priority growth sectors including real estate, infrastructure, clean energy and the UK's Industrial Strategy

  • Catherine McKinnell · DfE:

    2 Apr 2025

    Met Association of School and College Leaders

    Bilateral meeting as part of ongoing engagement with key sector partners

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met Moderna

    To discuss life sciences

  • Catherine McKinnell · DfE:

    2 Apr 2025

    Met The Confederation of School Trusts

    Bilateral meeting as part of ongoing engagement with key sector partners

  • Peter Kyle · DSIT

    2 Apr 2025

    Met Gilead Sciences

    To discuss Gilead's role in HIV prevention and issues facing the life sciences sector in the UK

  • Peter Kyle · DSIT

    2 Apr 2025

    Met Merck

    To discuss challenges and opportunities facing the UK life sciences sector, including medicines pricing, clincal trials and AI

  • Peter Kyle · DSIT

    2 Apr 2025

    Met Astrazeneca, Chiesi, Moderna, Menarini, Bristol-Mysers Squibb, Pfizer, Amgen, MSD, Johnson & Johnson, TEVA, Almirall, Merck, Incyte, Sanofi, Servier, IPSEN, Novartis, Gilead, Bayer, Chugai, Eli Lilly, Roche, USB, Mitsubishi, Lundbeck, Biogen, Takeda, Boehringer Ingelheim, GSK, Association of the British Pharmaceutical Idustry, JPMA, European Federation of Pharmaceutical Infustries and Association, Government Affairs Gilead Sciences, INTERPAT, International Federation of Pharmaceutical Manufacturers and Associations, Global Policy Roche, Pharmaceutical Research and Manufacturers of America, MHRA, John Symons, John Bell, Jason Chin, Wellcome Trust, University of Cambridge, University of Manchester, University of Oxford, Francis Crick Institute

    Roundtable discuss issues facing life sciences in the UK, including VPAG, clincial trials, and health data

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met Roche

    To discuss life sciences

  • Kerry McCarthy · DESNZ

    2 Apr 2025

    Met Fusion Industry Taskforce, Fusion Industry Association, The Fusion Cluster

    Chaired a Minister Led Fusion Industry Group to discuss the UK’s leading role in Fusion, R&D, and the UK's fusion strategy

  • Jonathan Reynolds · DBT’s

    2 Apr 2025

    Met Trade Strategy Roundtable: Aston Martin, Babcock, BP, Diageo, KPMG UK, Shell UK, Smith+Nephew, Starling Bank, Storegga, Synthesia

    To discuss the upcoming Trade Strategy with the Chancellor

  • Mike Kane · DfT ministerial external

    2 Apr 2025

    Met PD Ports

    Meeting to discuss Teesport Offshore Gateway offfshore wind hub development

  • Georgia Gould · Cabinet Office

    2 Apr 2025

    Met Strategy Group convened by Sir Bernard Jenkin MP

    A meeting to discuss opportunities around Civil Service Learning and Development.

  • Peter Hendy · DfT ministerial external

    2 Apr 2025

    Met Infracapital, Great British Rail Freight

    To discuss the Railways Bill Reform Condoc

  • Jennifer Chapman · FCDO

    2 Apr 2025

    Met African Development Bank

    To discuss the African Development Bank / UK's approach to development

  • Nick Thomas-Symonds · Cabinet Office

    2 Apr 2025

    Met Bloodloss Families, Blood Friends, UK Thalassaemia Society

    To give an update on the Government's response to the Infected Blood Inquiry.

  • Nick Thomas-Symonds · Cabinet Office

    2 Apr 2025

    Met Tainted Blood Parents, Tainted Blood Widows, Tainted Blood Siblings and Children, Factor 8, The Fatherless Generation, Independent Campaigner for Estates, Women & Carers

    To give an update on the Government's response to the Infected Blood Inquiry.

  • Nick Thomas-Symonds · Cabinet Office

    2 Apr 2025

    Met Tainted Blood, The Hepatitis C Trust, Terrence Higgins Trust, Contaminated Whole Blood

    To give an update on the Government's response to the Infected Blood Inquiry.

  • Wes Streeting · DHSC:

    2 Apr 2025

    Met GlaxoSmithKline (GSK)

    To discuss life sciences

  • Pat McFadden · Cabinet Office

    2 Apr 2025

    Met Future Resilience Forum

    Meeting to discuss the aims of the forum and options for ministerial engagement.

  • Patrick Vallance · DSIT

    2 Apr 2025

    Met AstraZeneca, Chiesi, Moderna, Menarini, Bristol - Myers Squibb, Pfizer, Amgen, MSD, Johnson and Johnson, TEVA, Almirall, Merck, Incyte, Sanofi, Servier, IPSEN, Eisai, Novartis, Gilead, Bayer, Chugai, Eli Lilly, Roche, USB, Mitsubishi, Lundbeck, Biogen, Boehringer Ingelheim, Takeda, GSK, University of Oxford, Ellison Institute for Technology, Wellcome Trust, University of Cambridge, University of Manchester, Francis Crick Institute

    Biopharmaceutical CEO Roundtable (BCR) Ministerial Policy Roundtable

  • Sir Keir Starmer · Rt Hon Sir Keir Starmer KCB KC MP

    2 Apr 2025

    Met AstraZeneca, GSK, Moderna, Eli Lilly, Johnson & Johnson, Roche Group, Novartis, MSD, Bristol-Myers Squibb, Amgen, Healthcare at Merck, Incyte, Gilead Sciences, Biogen, TEVA, Chiesi, Menarini, Almirall, Servier, IPSEN, Bayer, UCB, Lundbeck, Boehringer Ingelheim, Eisai, Chugai, Shinogi, Mitsubishi, Takeda Pharmaceutical Co, MHRA, NICE, NHSE, Wellcome Trust, University of Manchester

    Biopharmaceuticals CEOs Roundtable to discuss global health challenges and life sciences policy

  • Sir Keir Starmer · Rt Hon Sir Keir Starmer KCB KC MP

    2 Apr 2025

    Met Sir Gareth Southgate, Leaders in Sport

    To discuss how to tackle issues facing young men

  • Miatta Fahnbulleh · DESNZ

    2 Apr 2025

    Met Trustmark

    To discuss government-assured retrofitting measures

1-50 of 100